CELH
Earnings in 2 days · May 7, 2026 · Before open
Signal
Leaning Bearish1
Price
1
Move-0.47%Quiet session
Volume
1
Volume1.0× avgNormal activity
Technical
1
RSIRSI 37Momentum negative
PRICE
Prev Close
33.73
Open
33.71
Day Range33.30 – 34.49
33.30
34.49
52W Range32.01 – 66.74
32.01
66.74
4% of range
VOLUME & SIZE
Avg Volume
6.5M
FUNDAMENTALS
P/E Ratio
134.3x
Premium valuation
EPS (TTM)
Div Yield
No dividend
Beta
2.15
High vol
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +86% YoY · 50% gross margin
Valuation
EXPENSIVE
P/E 134x vs ~20x sector
Health
STRONG
CR 1.7 · FCF $1.37/sh
Bullish
Key MetricsTTM
Market Cap$8.62B
Revenue TTM$2.52B
Net Income TTM$108.00M
Free Cash Flow$323.38M
Gross Margin50.4%
Net Margin4.3%
Operating Margin8.8%
Return on Equity4.7%
Return on Assets2.1%
Debt / Equity0.23
Current Ratio1.68
EPS TTM$0.46

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong2 watch3 concern
42/100
Liquidity
1.68Watch
Leverage
0.23Strong
Coverage
4.5xWatch
ROE
4.7%Concern
ROIC
4.7%Concern
Cash
$399MConcern
ANALYST COVERAGE22 analysts
BUY
+86.2%upside to target
L $41.00
Med $62.50consensus
H $70.00
Buy
2091%
Hold
15%
Sell
15%
20 Buy (91%)1 Hold (5%)1 Sell (4%)
Full report →
Stock Health
Composite Score
3 of 4 signals bullish
8/10
Technicals
RSI RangeRSI 37 — Bearish momentum
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.68 — healthy liquidity

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings Report · After CloseMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 107 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 15.1%

-19.5% vs SMA 50 · -31.7% vs SMA 200

Momentum

RSI37.5
Momentum fading
MACD-2.03
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$66.74+98.8%
EMA 200
$45.49+35.5%
EMA 50
$40.23+19.8%
Current
$33.57
52W Low
$32.01-4.6%
52-Week RangeNear 52-week low
$32.014th %ile$66.74
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 18 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$2.4B
$2.4B$2.5B
$1.24
±6%
High18
FY2026(current)
$3.4B
$3.2B$3.5B
+38.5%$1.60+28.9%
±15%
High17
FY2027
$3.7B
$3.5B$4.0B
+9.8%$2.02+25.9%
±17%
High17
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCELH
Last 8Q
+37.9%avg beat
Beat 7 of 8 quartersMissed 1 Estimates rising
+13%
Q1'24
+42%
Q2'24
+17%
Q3'24
+27%
Q1'25
-10%
Q2'25
+123%
Q3'25
+54%
Q4'25
+37%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Morgan StanleyEqual-Weight → Overweight
Sep 30
UPGRADE
Bank of America Sec…Neutral → Underperform
Aug 8
DOWNGRADE
Bank of America Sec…Buy
May 10
UPGRADE
SVB LeerinkMarket Perform
Feb 6
DOWNGRADE
Raymond JamesMarket Perform
Feb 6
DOWNGRADE
Wells FargoOverweight
Feb 6
UPGRADE
Credit SuisseNeutral → Overweight
Feb 6
UPGRADE
BernsteinOutperform
Feb 6
UPGRADE
WedbushOutperform → Neutral
Feb 6
DOWNGRADE
Atlantic EquitiesNeutral
Feb 6
UPGRADE
WedbushNeutral → Outperform
Feb 6
UPGRADE
Maxim GroupBuy
May 11
UPGRADE
Insider Activity
SEC Filings →
0 Buys/1 SellNet Selling
Russell JoyceDir
$148K
Mar 2
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Pictet Asset Management Holding SA
677K
2
BRAUN STACEY ASSOCIATES INC
643K
3
Retirement Systems of Alabama
555K
4
EXCHANGE TRADED CONCEPTS, LLC
531K
5
CONGRESS ASSET MANAGEMENT CO /MA
529K
6
Nuveen, LLC
401K
7
Moran Wealth Management, LLC
248K
8
BW Gestao de Investimentos Ltda.
245K
News & Activity

CELH News

20 articles · 4h ago

About

Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CELSIUS® has five beverage lines that each offer proprietary, functional, healthy-energy formulas clinically-proven to offer significant health benefits to its users. The five lines include, CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® BCAA +Energy, CELSIUS® On-the-Go, and CELSIUS® Sweetened with Stevia. CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is Certified Kosher and Vegan. CELSIUS® is also soy and gluten-free and contains very little sodium. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. CELSIUS® is sold nationally at Target, CVS, Walmart, GNC, Vitamin Shoppe, 7-Eleven, Dick's Sporting Goods, The Fresh Market, Sprouts and other key regional retailers such as HEB, Publix, Winn-Dixie, Harris Teeter, Shaw's and Food Lion. It is also available on Amazon, at fitness clubs and in select micro-markets across the country.

Industry
Soft Drink Manufacturing
Paul WisemanSenior Vice President of Communications & Investor Relations
Brant BurchfieldSenior Vice President of Growth & Strategic Planning
Eric HansonPresident & Chief Operating Officer